The expression of the immune checkpoint regulator VISTA correlates with improved overall survival in pT1/2 tumor stages in esophageal adenocarcinoma

DOI: 10.1080/2162402X.2019.1581546

Keywords: Esophageal adenocarcinoma, VISTA, TILs, early tumor stages, prognosis

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text